Nine years after its founding, Retrovirology has moved to the forefront of virology journals in Impact Factor.
JAIDS, J Virol., Virology, J Gen Virology; and two established standards of molecular biology and biochemistry, the Journal of Molecular Biology and the Journal of Biological Chemistry (Figure 1 ). Of interest, amongst these journals, Retrovirology is the only Open Access journal. This means that only in Retrovirology are your papers immediately available for all to read, the very day that they are published, in full text form without the readers being encumbered by subscription fees. This Open Access feature may explain the large advantage in Immediacy Index for papers published in Retrovirology over the next-ranked journal, the Journal of Infectious Diseases (Figure 1 ). Impact Factor and Immediacy Index are two of several proxies of a journal's quality, and one should interpret cautiously their meaning [4] . Arguably, a better measure is to ask how a journal's papers have made a difference in its field. In this respect, a significant example can be drawn from six Retrovirology papers published in December 2010 that were the first to pivotally correct the then held belief that XMRV was an etiological cause of Chronic Fatigue Syndrome (CFS) [5] [6] [7] [8] [9] [10] . In that instance, Retrovirology's Open Access format was particularly instrumental in permitting interested individuals, who were not career scientists, to freely, rapidly, and fully access those paradigm-changing peer-reviewed publications.
Increasing data support the absence of inherent reasons for qualitative difference between papers published in subscription versus Open Access journals [11] . In my view, whether a journal moves to the fore is dictated by the diligence and dedication of its editorial board. Retrovirology's strong progress forward is owed to the efforts of its board members (http://www.retrovirology.com/ about/edboard). 
